On 23 February Received Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement - SEC Filing
28/02/2022 11:21
Feb 28 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* ALTERITY THERAPEUTICS LTD - ON 23 FEBRUARY RECEIVED
NON-COMPLIANCE NOTICE REGARDING NASDAQ MINIMUM BID PRICE
REQUIREMENT - SEC FILING
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital